NCT07097857

Brief Summary

To explore the usefulness of SFDI in the assessment of revascularization pre and post intervention

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 2, 2024

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

July 24, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 31, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

July 31, 2025

Status Verified

July 1, 2025

Enrollment Period

1.2 years

First QC Date

July 24, 2025

Last Update Submit

July 24, 2025

Conditions

Keywords

Spatial Frequency Domain ImagingPeripheral Arterial DiseaseNon-invasive imaging

Outcome Measures

Primary Outcomes (1)

  • Change in perfusion measured by tissue oxygen saturation

    Change in perfusion is assessed by level of tissue oxygen saturation measured pre and post revascularization to evaluate the usefulness of SFDI in the assessment of revascularization pre and post intervention.

    Pre and Post angioplasty on Day 0

Secondary Outcomes (1)

  • Compare SFDI measurements to Toe Pressure

    Pre and Post angioplasty on Day 0

Study Arms (1)

SFDI Imaging

EXPERIMENTAL

SFDI Imaging performed on both ipsilateral and contralateral foot. Imaging repeated on heel and pad regions of foot.

Other: SFDI

Interventions

SFDIOTHER

SFDI imaging is performed on both treated and untreated limb.

SFDI Imaging

Eligibility Criteria

Age21 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients of age 21 years and above with diabetes and undergoing lower limb arterial angioplasty
  • Willingness to participate in the study and undergo foot physiological assessments using SFDI

You may not qualify if:

  • Mentally incompetent, younger than 21 years of age, prisoners, pregnant or breastfeeding women
  • Patients unable to provide informed consent
  • Any medical condition which makes the candidate an inappropriate subject for study participation, in the investigator's judgment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Singapore General Hospital

Singapore, SG, 169856, Singapore

RECRUITING

Related Publications (2)

  • Lee S, Mey L, Szymanska AF, Takhar HS, Cuccia DJ, Mazhar A, Yu K. SFDI biomarkers provide a quantitative ulcer risk metric and can be used to predict diabetic foot ulcer onset. J Diabetes Complications. 2020 Sep;34(9):107624. doi: 10.1016/j.jdiacomp.2020.107624. Epub 2020 May 19.

    PMID: 32522482BACKGROUND
  • Amputation of limbs regarded as a last resort - Singapore General Hospital. (n.d.). Retrieved June 29, 2021, from https://www.sgh.com.sg/news/patient-care/amputation-of-limbs-regarded-as-a-last-resort

    BACKGROUND

MeSH Terms

Conditions

Peripheral Arterial Disease

Condition Hierarchy (Ancestors)

AtherosclerosisArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular DiseasesPeripheral Vascular Diseases

Study Officials

  • Tze Tec Chong

    Singapore General Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: Spatial Frequency Domain Imaging (SFDI) Imaging pre and post-ll angioplasty
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 24, 2025

First Posted

July 31, 2025

Study Start

October 2, 2024

Primary Completion

December 1, 2025

Study Completion

December 1, 2025

Last Updated

July 31, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

All data is protected by Personal Data Protection Act.

Locations